KIMBERLY NOLTE: Open Payments
NPI 1184809691 · FAIRHOPE, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$920 in 51 payments from 14 companies in 2025. Trend: 2023 $750 · 2024 $928 · 2025 $920
Food & beverage: $920
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $178 |
| Novo Nordisk Inc | 12 | $167 |
| Lilly USA, LLC | 5 | $100 |
| Exact Sciences Corporation | 5 | $99 |
| GlaxoSmithKline, LLC. | 4 | $65 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $63 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| ACADIA Pharmaceuticals Inc | 2 | $40 |
| Amgen Inc. | 2 | $37 |
| ABBVIE INC. | 1 | $30 |
Products named: FARXIGA, Ozempic, The Cologuard Plus Collection Kit, MOUNJARO, TRELEGY ELLIPTA, Kerendia, GEMTESA, DAYBUE.
Industry payments across AL — which companies pay providers there.
